The main aim of this research was the investigation of immunological effects of the type I interferon IFN and chemo-radio-immunotherapy with IFN and 5-FU in patients from the CapRI-2 trial, and in mice from the Panc02 orthotopic pancreatic carcinoma model. This evidence concerns the gene IFNA1 and exocrine pancreatic carcinoma.